Autoantibody explosion in antiphospholipid syndrome

Journal of Autoimmunity

Volumn 30, Issue 1-2, 2008, Pages 74-83

  Shoenfeld, Yehuda ^a   Twig, Gilad ^a   Katz, Uriel ^a   Sherer, Yaniv ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Anticardiolipin; Antiphospholipid syndrome; Autoantibody; Lupus anticoagulant; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; BETA2 GLYCOPROTEIN 1 ANTIBODY; BLOOD CLOTTING FACTOR; CARDIOLIPIN ANTIBODY; CELL SURFACE MARKER; GLYCOPROTEIN; LAMIN; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CORRELATION ANALYSIS; HUMAN; MITOCHONDRION; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; THROMBOCYTE;

ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; HUMANS; LUPUS COAGULATION INHIBITOR;

EID: 38049062431     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2007.11.011     Document Type: Article

References (69)

1. Sherer Y., and Shoenfeld Y. The antiphospholipid syndrome: an entity to be expanded. Am J Reprod Immunol 41 (1999) 113-116
2. Sherer Y., Gorstein A., Fritzler M.J., and Shoenfeld Y. Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Semin Arthritis Rheum 34 (2004) 501-537
3. Belizna C.C., Richard V., Thuillez C., Lévesque H., and Shoenfeld Y. Insights into atherosclerosis therapy in antiphospholipid syndrome. Autoimmun Rev 7 (2007) 46-51
4. Kajiwara T., Yasuda T., and Matsuura E. Intracellular trafficking of beta2-glycoprotein I complexes with lipid vesicles in macrophages: implications on the development of antiphospholipid syndrome. J Autoimmun 29 (2007) 164-173
5. Soltész P., Szekanecz Z., Kiss E., and Shoenfeld Y. Cardiac manifestations in antiphospholipid syndrome. Autoimmun Rev 6 (2007) 379-386
6. Koike T., Bohgaki M., Amengual O., and Atsumi T. Antiphospholipid antibodies: lessons from the bench. J Autoimmun 28 (2007) 129-133
7. Cavazzana I., Manuela N., Irene C., Barbara A., Sara S., Orietta B.M., et al. Complement activation in anti-phospholipid syndrome: a clue for an inflammatory process?. J Autoimmun 28 (2007) 160-164
8. Kiss E., Soltesz P., Der H., Kocsis Z., Tarr T., Bhattoa H., et al. Reduced flow-mediated vasodilation as a marker for cardiovascular complications in lupus patients. J Autoimmun 27 (2006) 211-217
9. Horkko S., Miller E., Branch D.W., Palinski W., and Witztum J.L. The epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and beta2 glycoprotein 1 (and other proteins). Proc Natl Acad Sci U S A 94 19 (1997) 10356-10361
10. Pierangeli S.S., Goldsmith G.H., Krnic S., and Harris E.N. Differences in functional activity of anticardiolipin antibodies from patients with syphilis and those with antiphospholipid syndrome. Infect Immun 62 9 (1994) 4081-4084
11. de Bandt M., Benali K., Guillevin L., Hachulla E., Job C., Fautrel B., et al. Longitudinal determination of antiphospholipid antibodies in lupus patients without previous manifestations of antiphospholipid syndrome. A prospective study. J Rheumatol 26 1 (1999) 91-96
12. Roubey R.A., Pratt C.W., Buyon J.P., and Winfield J.B. Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon beta 2-glycoprotein I. J Clin Invest 90 3 (1992) 1100-1104
13. Matsuura E., Igarashi Y., Fujimoto M., Ichikawa K., and Koike T. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 336 8708 (1990) 177-178
14. Roubey R.A., Maldonado M.A., and Byrd S.N. Comparison of an enzyme-linked immunosorbent assay for antibodies to beta 2-glycoprotein I and a conventional anticardiolipin immunoassay. Arthritis Rheum 39 9 (1996) 1606-1607
15. Audrain M.A., El-Kouri D., Hamidou M.A., Mioche L., Ibara A., Langlois M.L., et al. Value of autoantibodies to beta(2)-glycoprotein 1 in the diagnosis of antiphospholipid syndrome. Rheumatology (Oxford) 41 5 (2002) 550-553
16. Galli M., Ruggeri L., and Barbui T. Differential effects of anti-beta2-glycoprotein I and antiprothrombin antibodies on the anticoagulant activity of activated protein C. Blood 91 6 (1998) 1999-2004
17. Pengo V., Brocco T., Biasiolo A., Rampazzo P., Carraro P., and Zamarchi R. Procoagulant effect of anti-beta2-glycoprotein I antibodies with lupus anticoagulant activity. Blood 94 11 (1999) 3814-3819
18. de Laat H.B., Derksen R.H., Urbanus R.T., Roest M., and de Groot P.G. Beta2-glycoprotein I-dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndrome. Blood 104 12 (2004) 3598-3602 [Epub 2004 Aug 17]
19. Tubach F., Hayem G., Marchand J.L., Weber M., Palazzo E., de Bandt M., et al. IgG anti-beta2-glycoprotein I antibodies in adult patients with systemic lupus erythematosus: prevalence and diagnostic value for the antiphospholipid syndrome. J Rheumatol 27 6 (2000) 1437-1443
20. Harris E.N., Chan J.K., Asherson R.A., Aber V.R., Gharavi A.E., and Hughes G.R. Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test. Arch Intern Med 146 11 (1986) 2153-2156
21. Kalunian K.C., Peter J.B., Middlekauff H.R., Sayre J., Ando D.G., Mangotich M., et al. Clinical significance of a single test for anti-cardiolipin antibodies in patients with systemic lupus erythematosus. Am J Med 85 5 (1988) 602-608
22. Wilson W.A., Gharavi A.E., Koike T., Lockshin M.D., Branch D.W., Piette J.C., et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42 7 (1999) 1309-1311
23. Carmo-Pereira S., Bertolaccini M.L., Escudero-Contreras A., Khamashta M.A., and Hughes G.R. Value of IgA anticardiolipin and anti-beta2-glycoprotein I antibody testing in patients with pregnancy morbidity. Ann Rheum Dis 62 6 (2003) 540-543
24. Galli M., and Barbui T. Antiprothrombin antibodies: detection and clinical significance in the antiphospholipid syndrome. Blood 93 7 (1999) 2149-2157
25. Tsutsumi A., Matsuura E., Ichikawa K., Fujisaku A., Mukai M., Kobayashi S., et al. Antibodies to beta 2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus. Arthritis Rheum 39 9 (1996) 1466-1474
26. Cabiedes J., Cabral A.R., and Alarcon-Segovia D. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies. J Rheumatol 22 10 (1995) 1899-1906
27. Viard J.P., Amoura Z., and Bach J.F. Association of anti-beta 2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus. Am J Med 93 2 (1992) 181-186
28. Samarkos M., Asherson R.A., and Loizou S. The clinical significance of IgA antiphospholipid antibodies. J Rheumatol 28 4 (2001) 694-697
29. Languren M., Becerril B., Cabral A.R., Fernández-Altuna L.E., Pascual V., Hernández-Ramfrez D.F., et al. Characterization of monoclonal anti-beta2-glycoprotein-I and anti-prothrombin antibody fragments generated by phage display from a patient with primary antiphospholipid syndrome. J Autoimmun 26 (2006) 57-65
30. Ambrozic A., Cucnik S., Tomsic N., Urbanija J., Lokar M., Babnik B., et al. Interaction of giant phospholipid vesicles containing cardiolipin and cholesterol with beta2-glycoprotein-I and anti-beta2-glycoprotein-I antibodies. Autoimmun Rev 6 (2006) 10-15
31. Lopez-Soto A., Cervera R., Font J., Bove A., Reverter J.C., Munoz F.J., et al. Isotype distribution and clinical significance of antibodies to cardiolipin, phosphatidic acid, phosphatidylinositol and phosphatidylserine in systemic lupus erythematosus: prospective analysis of a series of 92 patients. Clin Exp Rheumatol 15 2 (1997) 143-149
32. Drouvalakis K.A., and Buchanan R.R. Phospholipid specificity of autoimmune and drug induced lupus anticoagulants: association of phosphatidylethanolamine reactivity with thrombosis in autoimmune disease. J Rheumatol 25 2 (1998) 290-295
33. Atsumi T., Ieko M., Bertolaccini M.L., Ichikawa K., Tsutsumi A., Matsuura E., et al. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant. Arthritis Rheum 43 9 (2000) 1982-1993
34. Berard M., Chantome R., Marcelli A., and Boffa M.C. Antiphosphatidylethanolamine antibodies as the only antiphospholipid antibodies. I. Association with thrombosis and vascular cutaneous diseases. J Rheumatol 23 8 (1996) 1369-1374
35. McIntyre J.A., and Wagenknecht D.R. Anti-phosphatidylethanolamine (aPE) antibodies: a survey. J Autoimmun 15 2 (2000) 185-193
36. Galli M., Willems G.M., Rosing J., Janssen R.M., Govers-Riemslag J.W., Comfurius P., et al. Anti-prothrombin IgG from patients with anti-phospholipid antibodies inhibits the inactivation of factor Va by activated protein C. Br J Haematol 129 2 (2005) 240-247
37. Medina G., Vera-Lastra O., Barile L., Salas M., and Jara L.J. Clinical spectrum of males with primary antiphospholipid syndrome and systemic lupus erythematosus: a comparative study of 73 patients. Lupus 13 1 (2004) 11-16
38. Carbone J., Orera M., Rodriguez-Mahou M., Rodriguez-Perez C., Sanchez-Ramon S., Seoane E., et al. Immunological abnormalities in primary APS evolving into SLE: 6 years follow-up in women with repeated pregnancy loss. Lupus 8 4 (1999) 274-278
39. Asherson R.A., and Shoenfeld Y. The significance of antibodies to DNA in the primary antiphospholipid syndrome. Clin Exp Rheumatol 12 1 (1994) 1-3
40. Panzer S., Gschwandtner M.E., Hutter D., Spitzauer S., and Pabinger I. Specificities of platelet autoantibodies in patients with lupus anticoagulants in primary antiphospholipid syndrome. Ann Hematol 74 5 (1997) 239-242
41. Bertolaccini M.L., Mepani K., Sanna G., Hughes G.R., and Khamashta M.A. Factor XII autoantibodies as a novel marker for thrombosis and adverse obstetric history in patients with systemic lupus erythematosus. Ann Rheum Dis 66 4 (2007) 533-536
42. Bidot C.J., Jy W., Horstman L.L., Huisheng H., Jimenez J.J., Yaniz M., et al. Factor VII/VIIa: a new antigen in the anti-phospholipid antibody syndrome. Br J Haematol 120 4 (2003) 618-626
43. Erkan D., Zhang H.W., Shriky R.C., and Merrill J.T. Dual antibody reactivity to beta2-glycoprotein I and protein S: increased association with thrombotic events in the antiphospholipid syndrome. Lupus 11 4 (2002) 215-225
44. Alpert D., Mandl L.A., Erkan D., Yin W., Peerschke E.I., and Salmon J.E. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome. Ann Rheum Dis (2007) [Epub ahead of print]
45. Cesarman-Maus G., Rios-Luna N.P., Deora A.B., Huang B., Villa R., Cravioto Mdel C., et al. Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome. Blood 107 11 (2006) 4375-4382
46. Esposito G., Tamby M.C., Chanseaud Y., Servettaz A., Guillevin L., and Mouthon L. Anti-annexin V antibodies: are they prothrombotic?. Autoimmun Rev 4 (2005) 55-60
47. Yang C.D., Hwang K.K., Yan W., Gallagher K., FitzGerald J., Grossman J.M., et al. Identification of anti-plasmin antibodies in the antiphospholipid syndrome that inhibit degradation of fibrin. J Immunol 172 9 (2004) 5765-5773
48. Cugno M., Cabibbe M., Galli M., Meroni P.L., Caccia S., Russo R., et al. Antibodies to tissue-type plasminogen activator (tPA) in patients with antiphospholipid syndrome: evidence of interaction between the antibodies and the catalytic domain of tPA in 2 patients. Blood 103 6 (2004) 2121-2126
49. Lu C.S., Horizon A.A., Hwang K.K., FitzGerald J., Lin W.S., Hahn B.H., et al. Identification of polyclonal and monoclonal antibodies against tissue plasminogen activator in the antiphospholipid syndrome. Arthritis Rheum 52 12 (2005) 4018-4027
50. Lean S.Y., Ellery P., Ivey L., Thom J., Oostryck R., Leahy M., et al. The effects of tissue factor pathway inhibitor and anti-beta-2-glycoprotein-I IgG on thrombin generation. Haematologica 91 10 (2006) 1360-1366
51. Hurtado V., Montes R., Gris J.C., Bertolaccini M.L., Alonso A., Martinez-Gonzalez M.A., et al. Autoantibodies against EPCR are found in antiphospholipid syndrome and are a risk factor for fetal death. Blood 104 5 (2004) 1369-1374
52. van Hylckama Vlieg A., Montes R., Rosendaal F.R., and Hermida J. Autoantibodies against endothelial protein C receptor and the risk of a first deep vein thrombosis. J Thromb Haemost 5 7 (2007) 1449-1454
53. de Larranaga G.F., Remondino G., Alonso B.S., and Voto L. Soluble thrombomodulin levels among women with a history of recurrent pregnancy loss, with or without antiphospholipid antibodies. Blood Coagul Fibrinolysis 16 1 (2005) 31-35
54. Pelegri Y., Cerrato G., Martinuzzo M.E., Carreras L.O., and Forastiero R.R. Link between anti-CD36 antibodies and thrombosis in the antiphospholipid syndrome. Clin Exp Rheumatol 21 2 (2003) 221-224
55. Boura P., Tselios K., Skendros P., and Kountouras J. Antiphospholipid syndrome in Greece: clinical and immunological study and review of the literature. Angiology 55 4 (2004) 421-430
56. Merkel P.A., Polisson R.P., Chang Y., Skates S.J., and Niles J.L. Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann Intern Med 126 11 (1997) 866-873
57. La Rosa L., Covini G., Galperin C., Catelli L., Del Papa N., Reina G., et al. Anti-mitochondrial M5 type antibody represents one of the serological markers for anti-phospholipid syndrome distinct from anti-cardiolipin and anti-beta2-glycoprotein I antibodies. Clin Exp Immunol 112 1 (1998) 144-151
58. Andrejevic S., Bonaci-Nikolic B., Sefik-Bukilica M., and Petrovic R. Clinical and serological follow-up of 71 patients with anti-mitochondrial type 5 antibodies. Lupus 16 10 (2007) 788-793
59. Galve-de Rochemonteix B., Kobayashi T., Rosnoblet C., Lindsay M., Parton R.G., Reber G., et al. Interaction of anti-phospholipid antibodies with late endosomes of human endothelial cells. Arterioscler Thromb Vasc Biol 20 2 (2000) 563-574
60. Alessandri C., Bombardieri M., Di Prospero L., Conigliaro P., Conti F., Labbadia G., et al. Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus. Clin Exp Immunol 140 1 (2005) 173-180
61. Shamir R., Shoenfeld Y., Blank M., Eliakim R., Lahat N., Sobel E., et al. The prevalence of coeliac disease antibodies in patients with the antiphospholipid syndrome. Lupus 12 5 (2003) 394-399
62. De Carolis C., Greco E., Guarino M.D., Perricone C., Dal Lago A., Giacomelli R., et al. Anti-thyroid antibodies and antiphospholipid syndrome: evidence of reduced fecundity and of poor pregnancy outcome in recurrent spontaneous aborters. Am J Reprod Immunol 52 4 (2004) 263-266
63. Dieude M., Senecal J.L., and Raymond Y. Induction of endothelial cell apoptosis by heat-shock protein 60-reactive antibodies from anti-endothelial cell autoantibody-positive systemic lupus erythematosus patients. Arthritis Rheum 50 10 (2004) 3221-3231
64. Senecal J.L., Rauch J., Grodzicky T., Raynauld J.P., Uthman I., Nava A., et al. Strong association of autoantibodies to human nuclear lamin B1 with lupus anticoagulant antibodies in systemic lupus erythematosus. Arthritis Rheum 42 7 (1999) 1347-1353
65. Vlachoyiannopoulos P.G., Mavragani C.P., Bourazopoulou E., Balitsari A.V., and Routsias J.G. Anti-CD40 antibodies in antiphospholipid syndrome and systemic lupus erythematosus. Thromb Haemost 92 6 (2004) 1303-1311
66. Bagnasco M., Grassia L., and Pesce G. The management of the patient with unexpected autoantibody positivity. Autoimmun Rev 6 (2007) 347-353
67. Muscal E., and Myones B.L. The role of autoantibodies in pediatric neuropsychiatric systemic lupus erythematosus. Autoimmun Rev 6 (2007) 215-217
68. Borchers A.T., Aoki C.A., Naguwa S.M., Keen C.L., Shoenfeld Y., and Gershwin M.E. Neuropsychiatric features of systemic lupus erythematosus. Autoimmun Rev 4 (2005) 329-344
69. Wu R., Shen G., Morris R., Patnaik M., and Peter J.B. Elevated autoantibodies against oxidized palmitoyl arachidonoyl phosphocholine in patients with hypertension and myocardial infarction. J Autoimmun 24 (2005) 353-360